POS0550 LONG TERM EFFICACY OF A 2-YEAR MRI TREAT-TO-TARGET STRATEGY ON DISEASE ACTIVITY, MRI INFLAMMATION AND PHYSICAL FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION: FIVE YEAR FOLLOW-UP OF THE IMAGINE RA-COHORT

Autor: Møller-Bisgaard, S., Hørslev-Petersen, K., Glinatsi, D., Ejbjerg, B., Hetland, M. L., Møllenbach Møller, J., Christensen, R., Nielsen, S. M., Boesen, M., Stengaard-Pedersen, K., Madsen, O., Jensen, B., Villadsen, J. A., Hauge, E. M., Hendricks, O., Lindegaard, H. M., Steen Krogh, N., Jurik, A. G., Thomsen, H., Østergaard, M.

Publikováno v: Møller-Bisgaard, S, Hørslev-Petersen, K, Glinatsi, D, Ejbjerg, B, Hetland, M L, Møllenbach Møller, J, Christensen, R, Nielsen, S M, Boesen, M, Stengaard-Pedersen, K, Madsen, O, Jensen, B, Villadsen, J A, Hauge, E M, Hendricks, O, Lindegaard, H M, Steen Krogh, N, Jurik, A G, Thomsen, H & Østergaard, M 2022, ' POS0550 Long term efficacy of a 2-year MRI treat-to-target strategy on disease activity, MRI inflammation and physical function in rheumatoid arthritis patients in clinical remission: five year follow-up of the imagine RA-cohorton ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl 1, pp. 539-540 . https://doi.org/10.1136/annrheumdis-2022-eular.3095

BackgroundTargeting MRI remission in rheumatoid arthritis (RA) patients in clinical remission may improve long term clinical, functional and MRI outcomes.ObjectivesTo investigate whether a 2-year treat-to-target (T2T) strategy, based on structured MR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bccd9eccaeea0b2dc76aef7a321fa0b1
https://doi.org/10.1136/annrheumdis-2022-eular.3095

How to get from the multidimensional health assessment questionnaire to stanford health assessment questionnaire disability index scores in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis:development and validation of a conversion algorithm

Autor: Svensson, E., Løngaard, K., Midtbøll Ørnbjerg, L., Meincke, R., Pedersen, J. K., Dreyer, L., Steen Krogh, N., Jensen, D. V., Hetland, M. L.

Publikováno v: Svensson, E, Løngaard, K, Midtbøll Ørnbjerg, L, Meincke, R, Pedersen, J K, Dreyer, L, Steen Krogh, N, Jensen, D V & Hetland, M L 2020, ' How to get from the multidimensional health assessment questionnaire to stanford health assessment questionnaire disability index scores in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis : development and validation of a conversion algorithm ', Annals of the Rheumatic Diseases, vol. 79, no. Suppl. 1, FRI0586, pp. 897-898 . https://doi.org/10.1136/annrheumdis-2020-eular.1292

Background: In the DANBIO quality registry in Denmark, patients with rheumatoid arthritis (RA) psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) have reported Patient Reported Outcomes (PROs) including the Stanford Health Assessment Quest

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::58e903ed0f650ea646985c3373cec745
https://vbn.aau.dk/da/publications/720f2b75-2504-44bc-ba3f-2240e3b12c4e

How to get from the multidimensional health assessment questionnaire to Stanford health assessment questionnaire disability index scores in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: Development and validation of a conversion algorithm

Autor: Svensson, E., Løngaard, K., Midtbøll Ørnbjerg, L., Rikke Hodal Meincke, Jens Kristian Pedersen, Dreyer, L., Steen Krogh, N., Jensen, D. V., Hetland, M. L.

Publikováno v: Svensson, E, Løngaard, K, Midtbøll Ørnbjerg, L, Meincke, R H, Pedersen, J K, Dreyer, L, Steen Krogh, N, Jensen, D V & Hetland, M L 2020, ' How to get from the multidimensional health assessment questionnaire to Stanford health assessment questionnaire disability index scores in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: Development and validation of a conversion algorithm ', Annals of the Rheumatic Diseases, vol. 79, no. Suppl. 1, pp. 897-898 . < http://ard.bmj.com/content/79/Suppl_1/897.1.abstract >
University of Southern Denmark

Background: In the DANBIO quality registry in Denmark, patients with rheumatoid arthritis (RA) psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) have reported Patient Reported Outcomes (PROs) including the Stanford Health Assessment Quest

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::61b1a5b36234ceabe0222ed7f658e64e
http://ard.bmj.com/content/79/Suppl_1/897.1.abstract

MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: secondary analyses of the imagine-ra trial

Autor: Signe Moller-Bisgaard, Kim Hørslev-Petersen, Bo Jannik Ejbjerg, Merete Lund Hetland, Christensen, R., Lykke Ornbjerg, Daniel Glinatski, Møllenbach Møller, J., Boesen, M., Kristian Stengaard-Pedersen, Ole Rintek Madsen, Jensen, B., Villadsen, J., Ellen Margrethe Hauge, Philip Bennett, Oliver Hendricks, Asmussen, K., Kowalski, M., Lindegaard, H. M., Henning Bliddal, Steen Krogh, N., Torkell Ellingsen, Nielsen, A., Anne Grethe Jurik, Balding, L., Thomsen, H., Østergaard, M.

Publikováno v: University of Southern Denmark
Moller-Bisgaard, S, Hørslev-Petersen, K, Ejbjerg, B J, Hetland, M L, Christensen, R, Ornbjerg, L, Glinatski, D, Møller, J M, Boesen, M, Stengaard-Pedersen, K, Madsen, O R, Jensen, B, Villadsen, J, Hauge, E M, Bennett, P, Hendricks, O, Asmussen, K, Kowalski, M, Lindegaard, H M, Bliddal, H, Steen Krogh, N, Ellingsen, T J, Nielsen, A, Jurik, A G, Balding, L, Thomsen, H & Østergaard, M 2020, ' MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: secondary analyses of the imagine-ra trial ', Annals of the Rheumatic Diseases, vol. 79, no. Suppl. 1, pp. 577-578 . < https://ard.bmj.com/content/79/Suppl_1/581 >
Møller-Bisgaard, S, Hørslev-Petersen, K, Ejbjerg, B J, Hetland, M L, Christensen, R, Ornbjerg, L, Glinatsi, D, Møller, J M, Boesen, M, Stengaard-Pedersen, K, Madsen, O R, Jensen, B, Villadsen, J, Hauge, E M, Bennett, P, Hendricks, O, Asmussen, K, Kowalski, M, Lindegaard, H M, Bliddal, H, Steen Krogh, N, Ellingsen, T J, Nielsen, A, Jurik, A G, Balding, L, Thomsen, H & Østergaard, M 2020, ' MRI INFLAMMATION, DISEASE ACTIVITY AND FUNCTIONAL IMPAIRMENT ARE MORE EFFECTIVELY REDUCED BY ESCALATION TO BIOLOGICS COMPARED TO CSDMARD-ESCALATION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY: SECONDARY ANALYSES OF THE IMAGINE-RA TRIAL ', EULAR 2020, 03/06/2020-06/06/2020 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::068cb4256eaae83d90866ff051018b42
https://portal.findresearcher.sdu.dk/en/publications/d62bb874-8fd5-446d-96ef-637212b445fa